NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ByMyCell

ByMyCell

Private
Ribeirão PretoHealthcare & Life Scienceshttps://bymycell.com.br/

Last Round

Accelerator

May 1, 2025

Total Funding Raised

$320,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ByMyCell is a biotechnology company that provides genomic sequencing and data analysis services for the agricultural and research sectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Environmental Monitoring, Cloud Infrastructure

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

genomic sequencingsoil microbiomemetagenomic analysisbioinformaticsagtechnext-generation sequencingNGSsoil healthprecision agriculturewhole genome sequencingbioinformatics consultingpathogen identificationdata as a serviceDaaSagronomic insights

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ByMyCell Comps

Public and private peers based on sector, stage, and business model.

ByMyCell comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ByMyCell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 1, 2025
SeedJan 31, 2024
GrantAug 27, 2023
AngelMar 31, 2022

Key People

Founding team and executive leadership

Rafael Silva-Rocha

CEO CTO at ByMyCell

Executive Team

ByMyCell Investors

Notable investors and investment history

ByMyCell investors
InvestorRounds
FAPESPGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors increased 259% MoM, reaching 1.4K.

ByMyCell Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ByMyCell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ByMyCell's valuation, stock price, and market status.

Firmographic Details

HeadquartersRibeirão Preto
Employee Range26
Year Founded2021
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.